Table 6.
Partial correlations between serum L-carnitine, TMAO levels with components of MS in females and males with hyperglycemia.
| Male (n = 136) | Female (n = 79) | |||
|---|---|---|---|---|
| r1(P) | r2(P) | r1(P) | r3(P) | |
| L-CARNITINE (μmol/L) | ||||
| Weight | 0.058(0.510) | 0.051(0.564) | 0.193 (0.093) | 0.213(0.074) |
| BMI | 0.108(0.217) | 0.079(0.378) | 0.157 (0.174) | 0.155(0.197) |
| Waist circumference | 0.081(0.352) | 0.019(0.833) | 0.130(0.260) | 0.143(0.234) |
| Hip circumference | 0.160(0.066) | 0.093(0.295) | 0.210(0.066) | 0.197(0.099) |
| Waist/hip ratio | −0.113(0.196) | −0.126(0.157) | −0.41(0.724) | 0.005(0.966) |
| Systolic BP | 0.018(0.831) | −0.021(0.816) | 0.103(0.366) | 0.108(0.378) |
| Diastolic BP | −0.005(0.956) | −0.116(0.194) | 0.099(0.384) | 0.174(0.153) |
| Serum TG | 0.218(0.011) | 0.180(0.044) | 0.040 (0.726) | −0.005(0.965) |
| Serum TC | 0.067(0.440) | 0.105(0.244) | 0.030(0.794) | 0.094(0.444) |
| Serum HDL-c | 0.052(0.551) | 0.124(0.166) | 0.130(0.252) | 0.266(0.027) |
| Serum LDL-c | −0.045(0.601) | −0.004(0.965) | −0.041(0.718) | −0.010(0.934) |
| Atherogenic index (AI) | −0.016(0.849) | −0.052(0.561) | −0.101(0.377) | −0.161(0.186) |
| Serum glucose | −0.100(0.245) | −0.124(0.167) | −0.040(0.724) | −0.105(0.391) |
| Serum insulin | 0.138(0.109) | 0.046(0.610) | 0.084 (0.464) | −0.066(0.589) |
| HOMA-IR | 0.115(0.182) | 0.020(0.820) | 0.070(0.538) | −0.084(0.492) |
| HOMA-β | 0.085(0.324) | −0.010(0.912) | 0.056 (0.626) | −0.098(0.425) |
| QUICKI | −0.133(0.123) | −0.039(0.667) | −0.099(0.385) | 0.055(0.651) |
| TMAO (μmol/L) | ||||
| Weight | 0.014(0.871) | 0.003(0.970) | 0.022(0.851) | 0.005(0.969) |
| BMI | 0.044(0.612) | 0.001(0.995) | −0.116(0.315) | −0.122(0.311) |
| Waist circumference | 0.035(0.693) | −0.007(0.940) | −0.034(0.771) | −0.056(0.644) |
| Hip circumference | 0.109(0.213) | 0.044(0.619) | −0.025(0.831) | −0.029(0.813) |
| Waist/hip ratio | −0.127(0.144) | −0.097(0.297) | −0.051(0.659) | −0.089(0.461) |
| Systolic BP | 0.086(0.321) | 0.022(0.810) | −0.123(0.281) | −0.142(0.246) |
| Diastolic BP | 0.096(0.265) | −0.022(0.805) | −0.105(0.357) | −0.088(0.472) |
| Serum TG | −0.095(0.271) | −0.139(0.122) | −0.134(0.240) | −0.145(0.235) |
| Serum TC | −0.110(0.201) | −0.069(0.443) | −0.029(0.798) | 0.008(0.949) |
| Serum HDL-c | 0.079(0.360) | 0.096(0.287) | 0.085(0.454) | 0.137(0.262) |
| Serum LDL-c | −0.080(0.352) | −0.027(0.765) | −0.015(0.896) | −0.007(0.956) |
| Atherogenic index (AI) | −0.149(0.083) | −0.129(0.150) | −0.150(0.188) | −0.154(0.205) |
| Serum glucose | 0.153(0.075) | 0.088(0.328) | 0.074(0.519) | 0.075(0.540) |
| Serum insulin | 0.211(0.014) | 0.172(0.045) | 0.028(0.809) | 0.074(0.544) |
| HOMA-IR | 0.235(0.006) | 0.188(0.035) | 0.041(0.720) | 0.085(0.486) |
| HOMA-β | 0.252(0.003) | 0.197(0.027) | 0.053(0.642) | 0.092(0.452) |
| QUICKI | −0.221(0.010) | −0.175(0.049) | −0.044(0.699) | −0.092(0.450) |
r1: correlation coefficient; r2: controlled for age, total calorie intake, physical activity level, medicine status, alcohol intake, smoking status; r3 controlled for age, total calorie intake, physical activity level, medicine status, alcohol intake, smoking status and menopausal status; Statistical significance was set to p < 0.05.